Top 5 Most-Read DMD Articles of 2023
This year’s top content in the Duchenne muscular dystrophy (DMD) space focused on a novel gene therapy approval, the high cost of care for this genetic disorder, and steps forward in other treatments.
United States Sarah Boyce Health Care Resource Utilization Santhera Pharmaceuticals American Journal Treat Duchenne Muscular
Source: ajmc.com